Get to know Korean companies in BioPharma establishing a footprint in the US market sponsored by K-Blockbuster project.
K-Blockbuster project is a long-term government project led by the Ministry of Health and Welfare of Korea to help Korea Bio Pharma companies to get into the US market successfully. The Korean government spares no effort in supporting companies throughout the entire period in resources, consulting and networking aspects.
Who's in the Room?
MedySapiens: MedySapiens is an emerging leader in cognitive computing for healthcare. Our solution combines the power of artificial intelligence and genomics to support healthcare providers and improve the quality of life not only for patients but also for the entire humanity.
Biotoxtech: Biotoxtech is Non-clinical CRO for IND/NDA enabling studies.
Standigm: Standigm is a drug discovery company that searches for new therapeutic targets and designs lead compounds using advanced artificial intelligence (AI) methods trained on big biomedical data as well as patient data.
Abion: ABION Inc. is a revolutionary new drug development company based on companion diagnostics technology. It is developing innovative drugs such as anti-cancer drug ABN401, broad spectrum Anti-viral drug ABN101, and emergency medicine for biological disasters.
Youth Bio Global: YBG has expertise in the regenerative medicines targeting the ischemic vascular diseases(such as critical limb ischemia, acute myocardiac infarction, diabetic retinopathy, stroke, etc.) using xeno-free EPC(XenoFree Endothelial Progenitor Cells) derived from human umbilical cord blood.
HAII: HAII (Human AI Interaction) is developing AI-based digital therapeutics for the diagnosis and treatment of CNS disease such as Alzheimer’s and Stroke.